4//SEC Filing
Dethlefs Sven 4
Accession 0001209191-23-007950
CIK 0000818686other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 7:02 AM ET
Size
5.9 KB
Accession
0001209191-23-007950
Insider Transaction Report
Form 4
Dethlefs Sven
EVP Global Marketing&Portfolio
Transactions
- Award
Restricted Share Units
2023-02-07+42,309→ 42,309 total→ Ordinary Shares (42,309 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 28, 2023.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001726010
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 7:02 AM ET
- Size
- 5.9 KB